• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白血病抑制因子(LIF)受体gp190免疫球蛋白样结构域中的突变会增加或降低其对LIF的亲和力。

Mutations in the immunoglobulin-like domain of gp190, the leukemia inhibitory factor (LIF) receptor, increase or decrease its affinity for LIF.

作者信息

Bitard Juliette, Daburon Sophie, Duplomb Laurence, Blanchard Frédéric, Vuisio Patricia, Jacques Yannick, Godard Anne, Heath John K, Moreau Jean-François, Taupin Jean-Luc

机构信息

CNRS UMR 5540, Université de Bordeaux 2, 146 rue Léo Saignat, 33076 Bordeaux, France.

出版信息

J Biol Chem. 2003 May 2;278(18):16253-61. doi: 10.1074/jbc.M207193200. Epub 2003 Feb 24.

DOI:10.1074/jbc.M207193200
PMID:12601009
Abstract

The leukemia inhibitory factor (LIF) receptor comprises the low affinity binding chain gp190 and the high affinity converter gp130. The ectodomain of gp190 is among the most complex in the hematopoietin receptor family, because it contains two typical cytokine receptor homology domains separated by an immunoglobulin-like (Ig-like) domain. Human and murine gp190 proteins share 76% homology, but murine gp190 binds human LIF with a much higher affinity, a property attributed to the Ig-like domain. Using alanine-scanning mutagenesis of the Ig-like domain, we mapped a LIF binding site at its carboxyl terminus, mainly involving residue Phe-328. Mutation of selected residues into their orthologs in the murine receptor (Q251E and N321D) significantly increased the affinity for human LIF. Interestingly, these residues, although localized at both the amino and carboxyl terminus, make a spatially unique LIF binding site in a structural model of the Ig-like module. These results demonstrate definitively the role of the Ig-like domain in LIF binding and the potential to modulate receptor affinity in this family with very limited amino acid changes.

摘要

白血病抑制因子(LIF)受体由低亲和力结合链gp190和高亲和力转换链gp130组成。gp190的胞外结构域是造血因子受体家族中最为复杂的结构域之一,因为它包含两个典型的细胞因子受体同源结构域,中间由一个免疫球蛋白样(Ig样)结构域隔开。人和小鼠的gp190蛋白具有76%的同源性,但小鼠的gp190与人LIF的结合亲和力要高得多,这一特性归因于Ig样结构域。通过对Ig样结构域进行丙氨酸扫描诱变,我们在其羧基末端定位了一个LIF结合位点,主要涉及苯丙氨酸-328残基。将选定残基突变为小鼠受体中的对应残基(Q251E和N321D)显著提高了对人LIF的亲和力。有趣的是,这些残基虽然位于氨基末端和羧基末端,但在Ig样模块的结构模型中形成了一个空间上独特的LIF结合位点。这些结果明确证明了Ig样结构域在LIF结合中的作用,以及通过非常有限的氨基酸变化来调节该家族受体亲和力的潜力。

相似文献

1
Mutations in the immunoglobulin-like domain of gp190, the leukemia inhibitory factor (LIF) receptor, increase or decrease its affinity for LIF.白血病抑制因子(LIF)受体gp190免疫球蛋白样结构域中的突变会增加或降低其对LIF的亲和力。
J Biol Chem. 2003 May 2;278(18):16253-61. doi: 10.1074/jbc.M207193200. Epub 2003 Feb 24.
2
Separate functions for the two modules of the membrane-proximal cytokine binding domain of glycoprotein 190, the leukemia inhibitory factor low affinity receptor, in ligand binding and receptor activation.白血病抑制因子低亲和力受体糖蛋白190膜近端细胞因子结合域的两个模块在配体结合和受体激活方面具有不同功能。
J Biol Chem. 2002 Apr 19;277(16):13682-92. doi: 10.1074/jbc.M111624200. Epub 2002 Feb 7.
3
Leukemia inhibitory factor (LIF), cardiotrophin-1, and oncostatin M share structural binding determinants in the immunoglobulin-like domain of LIF receptor.白血病抑制因子(LIF)、心肌营养素-1和制瘤素M在LIF受体的免疫球蛋白样结构域中共享结构结合决定簇。
J Biol Chem. 2003 Jul 18;278(29):27169-79. doi: 10.1074/jbc.M303168200. Epub 2003 Apr 21.
4
Leukemia inhibitory factor (LIF) and oncastsin M (OSM) high affinity binding require additional receptor subunits besides GP130 and GP190.白血病抑制因子(LIF)和制瘤素M(OSM)的高亲和力结合除了需要GP130和GP190外,还需要其他受体亚基。
Cytokine. 1996 Mar;8(3):197-205. doi: 10.1006/cyto.1996.0028.
5
Binding of leukemia inhibitory factor (LIF) to mutants of its low affinity receptor, gp190, reveals a LIF binding site outside and interactions between the two cytokine binding domains.白血病抑制因子(LIF)与其低亲和力受体gp190突变体的结合揭示了一个位于外部的LIF结合位点以及两个细胞因子结合结构域之间的相互作用。
J Biol Chem. 1999 May 14;274(20):14482-9. doi: 10.1074/jbc.274.20.14482.
6
The upper cytokine-binding module and the Ig-like domain of the leukaemia inhibitory factor (LIF) receptor are sufficient for a functional LIF receptor complex.白血病抑制因子(LIF)受体的上部细胞因子结合模块和免疫球蛋白样结构域足以形成功能性LIF受体复合物。
J Mol Biol. 2002 Jan 25;315(4):637-46. doi: 10.1006/jmbi.2001.5282.
7
Identification of a gp130 cytokine receptor critical site involved in oncostatin M response.鉴定参与制瘤素M反应的gp130细胞因子受体关键位点。
J Biol Chem. 2000 Feb 25;275(8):5648-56. doi: 10.1074/jbc.275.8.5648.
8
Epitope-function relationships of human leukemia inhibitory factor receptors using a novel set of anti-gp190 mAB.使用一组新型抗gp190单克隆抗体研究人白血病抑制因子受体的表位-功能关系
Int Immunol. 1997 Dec;9(12):1775-84. doi: 10.1093/intimm/9.12.1775.
9
The mannose 6-phosphate/insulin-like growth factor II receptor is a nanomolar affinity receptor for glycosylated human leukemia inhibitory factor.甘露糖6-磷酸/胰岛素样生长因子II受体是糖基化人白血病抑制因子的纳摩尔亲和力受体。
J Biol Chem. 1998 Aug 14;273(33):20886-93. doi: 10.1074/jbc.273.33.20886.
10
Formation of autocrine loops in human cerebral meningioma tissue by leukemia inhibitor factor, interleukin-6, and oncostatin M: inhibition of meningioma cell growth in vitro by recombinant oncostatin M.白血病抑制因子、白细胞介素-6和制瘤素M在人脑膜瘤组织中形成自分泌环:重组制瘤素M对体外脑膜瘤细胞生长的抑制作用
J Neurosurg. 1998 Mar;88(3):541-8. doi: 10.3171/jns.1998.88.3.0541.

引用本文的文献

1
An engineered ligand trap inhibits leukemia inhibitory factor as pancreatic cancer treatment strategy.工程化配体陷阱抑制白血病抑制因子作为胰腺癌治疗策略。
Commun Biol. 2021 Apr 12;4(1):452. doi: 10.1038/s42003-021-01928-2.
2
An unusual cytokine:Ig-domain interaction revealed in the crystal structure of leukemia inhibitory factor (LIF) in complex with the LIF receptor.一种不同寻常的细胞因子:白血病抑制因子(LIF)与LIF受体复合物晶体结构中揭示的免疫球蛋白(Ig)结构域相互作用。
Proc Natl Acad Sci U S A. 2007 Jul 31;104(31):12737-42. doi: 10.1073/pnas.0705577104. Epub 2007 Jul 24.
3
Null leukemia inhibitory factor receptor (LIFR) mutations in Stuve-Wiedemann/Schwartz-Jampel type 2 syndrome.
施图韦-维德曼/施瓦茨-扬佩尔2型综合征中的白血病抑制因子受体(LIFR)无义突变
Am J Hum Genet. 2004 Feb;74(2):298-305. doi: 10.1086/381715. Epub 2004 Jan 21.